Tumor Necrosis Factor Alpha Inhibits Type I Collagen Synthesis through Repressive CCAAT/Enhancer-Binding Proteins

REFERENCES

• Ahn, S., Olive, M., Aggarwal, S., Krylov, D., Ginty, D. D., and Vinson, C.. 1998. A dominant negative inhibitor of CREB reveals that is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell. Biol. 18:967–977
   PubMed Web of Science ®Google Scholar
• Alevizopoulos, A., and Mermod, N.. 1996. Antagonistic regulation of a proline-rich transcription factor by transforming growth factor β and tumor necrosis factor α. J. Biol. Chem. 271:29672–29681
   PubMedGoogle Scholar
• Baker, S. J., and Reddy, E. P.. 1998. Modulation of life and death by the TNF receptor superfamily. Oncogene 17:3261–3270
   PubMed Web of Science ®Google Scholar
• Brenner, D. A., O'Hara, M., Angel, P., Chojkier, M., and Karin, M.. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature 337:661–663
   PubMed Web of Science ®Google Scholar
• Descombes, P., and Schibler, U.. 1991. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67:569–576
   PubMed Web of Science ®Google Scholar
• Fujita, T., Reis, L. F., Watanabe, N., Kimura, Y., Taniguchi, T., and Vilcek, J.. 1989. Induction of the transcription factor IRF-1 and interferon mRNAs by cytokines and activators of the second messenger pathways. Proc. Natl. Acad. Sci. USA 86:9936–9940
   PubMed Web of Science ®Google Scholar
• Greenwel, P., Hu, W., Kohanski, R. D., and Ramirez, F.. 1995. Tyrosine dephosphorylation of nuclear proteins mimics transforming growth factor β1 stimulation of α2(I) collagen gene expression. Mol. Cell. Biol. 15:6813–6819
   PubMedGoogle Scholar
• Inagaki, Y., Truter, S., Tanaka, M., Di Liberto, M., and Ramirez, F.. 1995. Overlapping pathways mediate the opposing actions of tumor necrosis factor-α and transforming growth factor-β on α2(I) collagen gene transcription. J. Biol. Chem. 263:13909–13915
   Google Scholar
• Kadonaga, J. T., and Tjian, R.. 1986. Affinity purification of sequence-specific DNA-binding proteins. Proc. Natl. Acad. Sci. USA 83:5889–5893
   PubMed Web of Science ®Google Scholar
• Kahari, V. M., Chen, Y. R., Bashir, M. M., Rosenbloom, J., and Uitto, J.. 1992. Tumor necrosis factor-α down-regulates human elastin gene expression. J. Biol. Chem. 267:26134–26141
   PubMed Web of Science ®Google Scholar
• Kahari, V. M., Chen, Y. Q., Su, M. W., Ramirez, F., and Uitto, J.. 1990. Tumor necrosis factor α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. J. Clin. Investig. 86:1489–1495
   PubMed Web of Science ®Google Scholar
• Lincoln, A. J., Monczak, Y., Williams, S. C., and Johnson, P. F.. 1998. Inhibition of CCAAT/enhancer-binding protein α and β translation by upstream open reading frames. J. Biol. Chem. 273:9552–9560
   PubMedGoogle Scholar
• McKnight, S. L.. 1992. CCAAT/enhancer binding protein Transcriptional regulation. McKnight, S. L., and Yamamoto, K. R. 771–795 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
   Google Scholar
• Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M., Reitman, M. L., and Vinson, C.. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168–3181
   PubMed Web of Science ®Google Scholar
• Nanes, M. S., Rubin, J., Titus, G., Hendy, G., and Catherwood, B. D.. 1991. Tumor necrosis factor alpha inhibits 1,25 dihydroxy-vitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Endocrinology 128:2577–2584
   PubMedGoogle Scholar
• Olive, M., Williams, S. C., Dezan, C., Johnson, P. F., and Vinson, C.. 1996. Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties. J. Biol. Chem. 271:2040–2047
   PubMedGoogle Scholar
• Ron, D., Braiser, A. R., McGehee, R. E., and Habener, J. F.. 1992. Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by loss of nuclear CCAAT/enhancer binding protein (C/EBP). J. Clin. Investig. 89:223–233
   PubMed Web of Science ®Google Scholar
• Rossi, P., Karsenty, G., Roberts, A. B., Roche, N. S., Sporn, M. B., and de Crombrugghe, B.. 1988. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor β. Cell 52:405–414
   PubMed Web of Science ®Google Scholar
• Solis-Herruzo, J. A., Brenner, D. A., and Chojkier, M.. 1988. Tumor necrosis factor α inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J. Biol. Chem. 263:5841–5845
   PubMed Web of Science ®Google Scholar
• Tracey, K. J., and Cerami, A.. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317–343
   PubMedGoogle Scholar
• Vallejo, M., Ron, D., Miller, C. P., and Habener, J. F.. 1993. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CCAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA 90:4679–4683
   PubMedGoogle Scholar
• Vinson, C. R., LaMarco, K. L., Johnson, P. F., Landschulz, W. H., and McKnight, S. L.. 1988. In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes Dev. 2:801–806
   PubMedGoogle Scholar
• Welm, A. L., Timchenko, N. A., and Darlington, G. J.. 1999. C/EBPα regulates generation of C/EBPβ isoforms through activation of specific proteolytic cleavage. Mol. Cell. Biol. 19:1695–1704
   PubMedGoogle Scholar